The Predicting Effect of ASXL1 Mutation on BCR-ABL Transcript Types and Responses to Tyrosine Kinase Inhibitors in Patients with Chronic Myeloid Leukemia. Medical Forum Monthly, [S. l.], v. 36, n. 8, 2025. DOI: 10.60110/medforum.360805. Disponível em: https://medicalforummonthly.com/index.php/mfm/article/view/5357.. Acesso em: 26 dec. 2025.